Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
RXi Pharmaceuticals Corporation
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in the prospectus constituting a part of this Registration Statement of our report dated March 26, 2018, relating to the consolidated financial statements of RXi Pharmaceuticals Corporation appearing in the Company’s Annual Report on Form10-K for the year ended December 31, 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Boston, Massachusetts
May 9, 2018
